Angiogenesis in Periodontal Disease
Smoking is Associated With Angiogenesis Through the Expression of FBXW7 and KLF2 in Periodontal Disease
1 other identifier
observational
114
1 country
1
Brief Summary
Gum disease (gingivitis and periodontitis) is a common inflammatory condition affecting the tissues that support the teeth. Smoking is known to make gum disease worse and to affect blood vessel health in the gums. This study looks at two proteins, KLF2 and FBXW7, which are involved in blood vessel formation, to understand their role in gum disease and whether smoking changes their levels. Researchers measured these proteins, along with two other markers of inflammation and blood vessel activity (VEGF and NF-κB), in fluid collected from around the teeth and in saliva from healthy adults who were either smokers or non-smokers, with healthy gums, gingivitis, or periodontitis. The goal is to better understand how smoking and gum disease affect blood vessel-related proteins in the mouth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
August 11, 2026
CompletedFirst Posted
Study publicly available on registry
August 14, 2026
CompletedAugust 14, 2026
August 1, 2026
7 months
August 11, 2026
August 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
GCF and Salivary VEGF, NF-κB, KLF2, and FBXW7 Protein Levels
Total amounts and concentrations of VEGF, NF-κB, KLF2, and FBXW7 were measured by ELISA in gingival crevicular fluid (GCF) and unstimulated whole saliva samples, and compared across participants with periodontal health, gingivitis, and periodontitis, in both smokers and non-smokers.
March to September 2024
Study Arms (6)
Group H
periodontally healthy and non smokers
Group G
gingivitis and non-smokers
Group P
periodontitis and non-smokers
Group S-H
periodontally healthy and non smokers
Group S-G
gingivitis and smokers
Group S-P
periodontitis and non-smokers
Eligibility Criteria
Adults aged 18 to 65 years attending the periodontology clinic were enrolled and classified into 6 groups based on clinical periodontal parameters and smoking status according to the 2017 World Workshop classification: periodontal health, gingivitis, and periodontitis (Stage III Grade B). Exclusion criteria included any systemic disease, regular medication use, pregnancy or lactation, periodontal treatment within the past 6 months, antibiotic use within the past 6 months, and presence of prosthetic restorations on the teeth to be sampled. A total of 114 participants (19 per group; 56 males, 58 females) were included.
You may qualify if:
- presence of ≥ 20 teeth in the mouth
- probing pocket depth (PPD) ≤ 3 mm
- the percentage of bleeding sites for the whole mouth \< 10%,
- on radiographic examination, a distance of ≤ 3 mm between the cemento-enamel junction and the alveolar bone crest in 95% of all teeth.
- presence of ≥ 20 teeth in the mouth
- PPD ≤ 3 mm,
- % of bleeding sites for the whole mouth ≥ 10%,
- on radiographic examination, a distance of ≤ 3 mm between the cemento-enamel junction and the alveolar bone crest in 95% of all teeth.
- presence of ≥ 15 teeth in the mouth
- more than 30% of teeth affected by periodontal disease
- affected teeth exhibiting probing depths of 6 mm or more
- clinical attachment loss (CAL) of ≥ 5 mm,
- vertical bone loss of 3 mm or more
- class 2 or 3 furcation involvement
- radiographic evidence of alveolar bone loss extending to the middle third and beyond (33%) in the relevant teeth
You may not qualify if:
- presence of any systemic disease
- regular use of any medication
- pregnancy or lactation
- periodontal treatment within the last 6 months
- antibiotic use within the last 6 months
- the presence of prosthetic restorations on the teeth to be sampled
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inonu Universitylead
Study Sites (1)
Inonu University, Faculty of Dentistry, Deparment of Periodontology
Malatya, 44100, Turkey (Türkiye)
Related Publications (4)
Afacan B, Ozturk VO, Pasali C, Bozkurt E, Kose T, Emingil G. Gingival crevicular fluid and salivary HIF-1alpha, VEGF, and TNF-alpha levels in periodontal health and disease. J Periodontol. 2019 Jul;90(7):788-797. doi: 10.1002/JPER.18-0412. Epub 2018 Dec 11.
PMID: 30536725BACKGROUNDLeite FRM, Nascimento GG, Scheutz F, Lopez R. Effect of Smoking on Periodontitis: A Systematic Review and Meta-regression. Am J Prev Med. 2018 Jun;54(6):831-841. doi: 10.1016/j.amepre.2018.02.014. Epub 2018 Apr 12.
PMID: 29656920BACKGROUNDKawanami D, Mahabeleshwar GH, Lin Z, Atkins GB, Hamik A, Haldar SM, Maemura K, Lamanna JC, Jain MK. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. J Biol Chem. 2009 Jul 31;284(31):20522-30. doi: 10.1074/jbc.M109.025346. Epub 2009 Jun 1.
PMID: 19491109BACKGROUNDArabi A, Ullah K, Branca RM, Johansson J, Bandarra D, Haneklaus M, Fu J, Aries I, Nilsson P, Den Boer ML, Pokrovskaja K, Grander D, Xiao G, Rocha S, Lehtio J, Sangfelt O. Proteomic screen reveals Fbw7 as a modulator of the NF-kappaB pathway. Nat Commun. 2012;3:976. doi: 10.1038/ncomms1975.
PMID: 22864569BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kubra Aral, Phd
Inonu University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 11, 2026
First Posted
August 14, 2026
Study Start
March 1, 2024
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
August 14, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 6 months and ending 24 months following article publicatio
- Access Criteria
- Data will be made available to researchers who provide a methodologically sound proposal, subject to approval by the corresponding author, for the purpose of achieving the aims outlined in the approved proposal.
De-identified individual participant data will be shared, including participant age, sex, and clinical periodontal parameters (plaque index, gingival index, probing depth, clinical attachment level, bleeding on probing). Participants will be identified only by coded/numbered case report forms; no names, gender identity beyond biological sex, or other identifying information will be shared.